- World rank, all time
- #22,628 of 42,892
- Rank in France
- #1,382 of 2,321
- Research works
- 208 ▼ 27% vs 2013–17
- Citations
- 7.5k 36.3 per fractional work
- Top-10% rate
- 14.9% record average 16.5%
- Open access
- 28% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.1×. Every wedge is a field page.
Who are the top researchers at Institut pour la Recherche sur le Cancer de Lille?
Ranked on the composite score, J Driessens, L Adenis and J Swyngedauw lead among researchers whose main affiliation is Institut pour la Recherche sur le Cancer de Lille.
- 1 J Driessens France · #1,224,486 worldwide 6 citations · 33 works
- 2 L Adenis France · #1,258,292 worldwide 16 citations · 18 works
- 3 J Swyngedauw France · #1,327,768 worldwide 1 citations · 48 works
Which keywords describe research at Institut pour la Recherche sur le Cancer de Lille?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Glycosylation, Prognostic Factors, Therapeutic Targets, Therapeutics, Immune System, Glycans and Mucins.
- Ribosome
- Antibody Engineering
- Oligosaccharide Synthesis
- Resistance
- Innate Immunity
- Drug Discovery
- Lymphoma
- Therapeutic Antibodies
- Gene Therapy
- DNA Structure
- Antisense Oligonucleotides
- Acute Myeloid Leukemia
- Gene Expression
- Hematopoietic Stem Cells
- Oxidative Stress
- Mucins
- Inflammation
- Cancer Therapy
- Therapeutic Targets
- Glycosylation
- Cancer
- Prognostic Factors
- Therapeutics
- Immune System
- Glycans
- Genomic Stability
- Apoptosis
- Chemotherapy
- AML
- Mutation
- Transcriptional Regulation
- G-Quadruplexes
- Monoclonal Antibodies
- Rituximab
- Antimicrobial Activity
- Anticancer Agents
- Targeted Therapy
- Glycosidase Inhibitors
- Translation
- Fc Receptors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer21▲ 7.2×31 topics
- Glycosylation14▲ 30×3 topics
- Prognostic Factors12▲ 12×10 topics
- Therapeutic Targets9▲ 19×6 topics
- Therapeutics9▲ 31×2 topics
- Cancer Therapy9▲ 6.8×14 topics
- Immune System9▲ 13×5 topics
- Inflammation9▲ 1.81×34 topics
- Glycans9▲ 51×1 topic
- Mucins9▲ 51×1 topic
- Genomic Stability8▲ 43×2 topics
- Oxidative Stress8▲ 2.1×30 topics
- Apoptosis7▲ 8.9×12 topics
- Hematopoietic Stem Cells7▲ 32×3 topics
- Chemotherapy6▲ 4.2×15 topics
- Gene Expression6▲ 4.7×14 topics
- AML6▲ 59×1 topic
- Acute Myeloid Leukemia6▲ 59×1 topic
- Mutation6▲ 17×3 topics
- Antisense Oligonucleotides5▲ 30×2 topics
- Transcriptional Regulation5▲ 10×9 topics
- DNA Structure5▲ 41×1 topic
- G-Quadruplexes5▲ 41×1 topic
- Gene Therapy5▲ 9.7×3 topics
- Monoclonal Antibodies5▲ 17×2 topics
- Therapeutic Antibodies5▲ 19×2 topics
- Rituximab5▲ 16×2 topics
- Lymphoma5▲ 16×3 topics
- Antimicrobial Activity5▲ 12×4 topics
- Drug Discovery5▲ 6.0×6 topics
- Anticancer Agents5▲ 9.2×6 topics
- Innate Immunity4▲ 6.2×8 topics
- Targeted Therapy4▲ 10×5 topics
- Resistance4▲ 17×2 topics
- Glycosidase Inhibitors4▲ 37×1 topic
- Oligosaccharide Synthesis4▲ 37×1 topic
- Translation4▲ 9.2×2 topics
- Antibody Engineering4▲ 19×1 topic
- Fc Receptors4▲ 19×1 topic
- Ribosome4▲ 18×1 topic
Which research topics does Institut pour la Recherche sur le Cancer de Lille publish most on?
By volume in 2022–2025: Acute Myeloid Leukemia Research, Pancreatic and Hepatic Oncology Research, Air Quality and Health Impacts and Alzheimer's disease research and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Myeloid Leukemia Research Hematology 0 works
- 2 Pancreatic and Hepatic Oncology Research Oncology 0 works
- 3 Air Quality and Health Impacts Health, Toxicology and Mutagenesis 0 works
- 4 Alzheimer's disease research and treatments Physiology 0 works
- 5 Caveolin-1 and cellular processes Cell Biology 0 works
- 6 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 0 works
- 7 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 8 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 9 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut pour la Recherche sur le Cancer de Lille's research output changed?
Output in 2018–2022 was 27% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lille
- Université de Lille
- Centre Hospitalier Universitaire de Lille
- Université Catholique de Lille
- Université Lille Nord de France
- Institut Pasteur de Lille
- Lille’s Cardiology Hospital
- Hôpital Claude Huriez
- Hôpital Roger Salengro
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.